These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 10342343

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Improvement of erythrocyte deformability by cholesterol-lowering therapy with pravastatin in hypercholesterolemic patients.
    Kohno M, Murakawa K, Yasunari K, Yokokawa K, Horio T, Kano H, Minami M, Yoshikawa J.
    Metabolism; 1997 Mar; 46(3):287-91. PubMed ID: 9054471
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Erythrocyte deformability in diabetes and erythrocyte membrane lipid composition.
    Garnier M, Attali JR, Valensi P, Delatour-Hanss E, Gaudey F, Koutsouris D.
    Metabolism; 1990 Aug; 39(8):794-8. PubMed ID: 2377077
    [Abstract] [Full Text] [Related]

  • 7. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
    Koter M, Franiak I, Broncel M, Chojnowska-Jezierska J.
    Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
    [Abstract] [Full Text] [Related]

  • 8. Influence of cholesterol lowering on plasma membrane lipids and cationic transport systems.
    Lijnen P, Celis H, Fagard R, Staessen J, Amery A.
    J Hypertens; 1994 Jan; 12(1):59-64. PubMed ID: 8157945
    [Abstract] [Full Text] [Related]

  • 9. Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia.
    Milani M, Cimminiello C, Merlo B, Lorena M, Arpaia G, Bonfardeci G.
    Am J Cardiol; 1995 Jul 13; 76(2):51A-53A. PubMed ID: 7604798
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Importance of high-density lipoprotein cholesterol control during pravastatin treatment in hypercholesterolemic Japanese with type 2 diabetes mellitus: a post hoc analysis of MEGA study.
    Nishimura R, Sone H, Nakagami T, Tajima N.
    Diabetes Res Clin Pract; 2013 May 13; 100(2):e31-3. PubMed ID: 23522341
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. I. A dose-response study.
    Hunninghake DB, Knopp RH, Schonfeld G, Goldberg AC, Brown WV, Schaefer EJ, Margolis S, Dobs AS, Mellies MJ, Insull W.
    Atherosclerosis; 1990 Nov 13; 85(1):81-9. PubMed ID: 2126437
    [Abstract] [Full Text] [Related]

  • 14. Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties.
    Uyuklu M, Meiselman HJ, Baskurt OK.
    Clin Hemorheol Microcirc; 2007 Nov 13; 36(1):25-33. PubMed ID: 17211059
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group.
    Jacotot B, Benghozi R, Pfister P, Holmes D.
    Am J Cardiol; 1995 Jul 13; 76(2):54A-56A. PubMed ID: 7604799
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.
    Eriksson M, Hådell K, Holme I, Walldius G, Kjellström T.
    J Intern Med; 1998 May 13; 243(5):373-80. PubMed ID: 9651560
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.